What is the current annual SG&A of NVS?

As of today, NVS annual SG&A is $0.00

What is 1-year change in NVS annual SG&A?

NVS annual SG&A is down -100.00% year-over-year

What is 3-year change in NVS annual SG&A?

NVS annual SG&A is down -100.00% over the past 3 years

How far is NVS annual SG&A from its all-time high?

NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on December 31, 2011

How does NVS annual SG&A rank versus sector peers?

NVS annual SG&A is higher than 72.89% of companies in Healthcare sector

When is NVS next annual earnings release?

As of today, the next annual earnings release for NVS has not been scheduled

What is the current quarterly SG&A of NVS?

As of today, NVS quarterly SG&A is $3.24B

What is NVS quarterly SG&A most recent change?

NVS quarterly SG&A was up +2.88% on June 30, 2026

What is 1-year change in NVS quarterly SG&A?

NVS quarterly SG&A is down -7.26% year-over-year

How far is NVS quarterly SG&A from its all-time high?

NVS quarterly SG&A is currently -36.15% below its historical high of $5.08B set on December 31, 2010

How does NVS quarterly SG&A rank versus sector peers?

NVS quarterly SG&A is higher than 99.44% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on October 27, 2026

What is the current TTM SG&A of NVS?

As of today, NVS TTM SG&A is $165.13B

What is NVS TTM SG&A most recent change?

NVS TTM SG&A was down -1.12% on June 30, 2026

What is 1-year change in NVS TTM SG&A?

NVS TTM SG&A is up +1150.79% year-over-year

How does NVS TTM SG&A rank versus sector peers?

NVS TTM SG&A is higher than 99.29% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on October 27, 2026

Novartis AG (NVS) SG&A History & Chart Since 1993

Annual SG&A

$0.00$12.56B-100.00%

December 31, 2025

Summary

Current Value: As of today, NVS annual SG&A is $0.00, down -100.00% on December 31, 2025
Historical Performance: NVS annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
All-Time High Comparison: NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on December 31, 2011
Sector Comparison: NVS annual SG&A is higher than 72.89% of companies in Healthcare sector

SG&A Chart

beforeafter

Performance

NVS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual SG&A	Dec 31, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Jun 30, 26	$3.24B	-7.3%	+4.9%	-13.6%	-35.2%
TTM SG&A	Jun 30, 26	$165.13B	+1150.8%	+1264.6%	+1029.0%	+799.5%
Price	Aug 19, 26	$160.69	+28.6%	+59.1%	+72.4%	+227.6%
Annual Operating Expenses	Dec 31, 25	$24.57B	+11.4%	+20.1%	+8.2%	-7.2%
Annual Operating Profit	Dec 31, 25	$16.47B	+6.8%	+58.6%	+52.2%	+77.5%
Annual D&A	Dec 31, 25	$5.35B	-11.8%	-20.3%	+4.7%	+116.0%
Annual Revenue	Dec 31, 25	$54.81B	+9.0%	+29.6%	+12.0%	+9.2%

SG&A Highs

NVS Annual SG&A Highs Comparison
Period	High	Date	Current
3Y	$12.56B	Dec 31, 24	-100.0%
5Y	$14.89B	Dec 31, 21	-100.0%
All	$17.86B	Dec 31, 11	-100.0%

SG&A Lows

NVS Annual SG&A Lows Comparison
Period	Low	Date	Current
3Y	$0.00	Dec 31, 25	N/A
5Y	$0.00	Dec 31, 25	N/A
All	$0.00	Dec 31, 25	N/A

SG&A History

Year	Value	Change
2025	$0.00	-100.0%
2024	$12.56B	+0.3%
2023	$12.52B	+2.7%
2022	$12.19B	-18.1%
2021	$14.89B	+4.9%
2020	$14.20B	-1.2%
2019	$14.37B	+4.8%
2018	$13.72B	-8.5%
2017	$15.00B	+5.7%
2016	$14.19B	-0.4%
2015	$14.25B	-5.0%
2014	$14.99B	-1.6%
2013	$15.24B	-11.9%
2012	$17.29B	-3.2%
2011	$17.86B	+14.0%
2010	$15.67B	+9.8%
2009	$14.28B	+1.4%

Year	Value	Change
2008	$14.08B	+6.2%
2007	$13.26B	+10.7%
2006	$11.97B	+8.1%
2005	$11.08B	+7.0%
2004	$10.35B	+11.9%
2003	$9.26B	+14.6%
2002	$8.08B	+7.5%
2001	$7.51B	-2.5%
2000	$7.71B	+4.9%
1999	$7.35B	+0.8%
1998	$7.29B	-2.6%
1997	$7.48B	-21.9%
1996	$9.58B	-1.4%
1995	$9.72B	+4.7%
1994	$9.29B	+2.9%
1993	$9.02B	-

FAQ

What is the current annual SG&A of NVS?: As of today, NVS annual SG&A is $0.00
What is 1-year change in NVS annual SG&A?: NVS annual SG&A is down -100.00% year-over-year
What is 3-year change in NVS annual SG&A?: NVS annual SG&A is down -100.00% over the past 3 years
How far is NVS annual SG&A from its all-time high?: NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on December 31, 2011
How does NVS annual SG&A rank versus sector peers?: NVS annual SG&A is higher than 72.89% of companies in Healthcare sector
When is NVS next annual earnings release?: As of today, the next annual earnings release for NVS has not been scheduled

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Quarterly SG&A

$3.24B$90.72M+2.88%

June 30, 2026

Summary

Current Value: As of today, NVS quarterly SG&A is $3.24B, up +2.88% on June 30, 2026
Historical Performance: NVS quarterly SG&A is down -7.26% year-over-year, up +4.92% over the past 3 years
All-Time High Comparison: NVS quarterly SG&A is currently -36.15% below its historical high of $5.08B set on December 31, 2010
3-Year Low Comparison: NVS quarterly SG&A is +14.20% above its 3-year low of $2.84B reached on March 31, 2024
Sector Comparison: NVS quarterly SG&A is higher than 99.44% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly SG&A	Jun 30, 26	$3.24B	+2.9%	-7.3%	+4.9%	-13.6%
Annual SG&A	Dec 31, 25	$0.00	–	-100.0%	-100.0%	-100.0%
TTM SG&A	Jun 30, 26	$165.13B	+1133.3%	+1150.8%	+1264.6%	+1029.0%
Price	Aug 19, 26	$160.69	+6.8%	+28.6%	+59.1%	+72.4%
Quarterly Operating Expenses	Jun 30, 26	$6.00B	+0.8%	-2.5%	+11.3%	+0.6%
Quarterly Operating Profit	Jun 30, 26	$4.74B	+26.1%	-0.4%	+75.5%	+54.1%
Quarterly D&A	Jun 30, 26	$1.40B	+13.6%	+18.8%	-17.9%	-3.0%
Quarterly Revenue	Jun 30, 26	$14.42B	+9.5%	+1.0%	+26.1%	+11.3%

Quarterly SG&A Highs

NVS Quarterly SG&A Highs Comparison
Period	High	Date	Current
1Y	$3.50B	N/A	-7.3%
3Y	$3.50B	Jun 30, 25	-7.3%
5Y	$3.99B	Dec 31, 21	-18.6%
All	$5.08B	Dec 31, 10	-36.1%

Quarterly SG&A Lows

NVS Quarterly SG&A Lows Comparison
Period	Low	Date	Current
1Y	$3.15B	Mar 31, 26	+2.9%
3Y	$2.84B	Mar 31, 24	+14.2%
5Y	$2.84B	Mar 31, 24	+14.2%
All	$0.00	Dec 31, 00	N/A

Quarterly SG&A History

Month	Value	Change
Jun 2026	$3.24B	+2.9%
Mar 2026	$3.15B	-8.4%
Dec 2025	$3.44B	+4.2%
Sep 2025	$3.30B	-5.6%
Jun 2025	$3.50B	+14.3%
Mar 2025	$3.06B	-12.0%
Dec 2024	$3.48B	+9.7%
Sep 2024	$3.17B	+2.5%
Jun 2024	$3.09B	+8.8%
Mar 2024	$2.84B	-17.5%
Dec 2023	$3.44B	+11.4%
Sep 2023	$3.09B	0.0%
Jun 2023	$3.09B	+6.9%
Mar 2023	$2.89B	-9.2%
Dec 2022	$3.18B	+8.4%
Sep 2022	$2.94B	-18.0%
Jun 2022	$3.58B	+2.0%
Mar 2022	$3.51B	-11.9%
Dec 2021	$3.99B	+10.1%
Sep 2021	$3.62B	-3.6%
Jun 2021	$3.75B	+6.4%
Mar 2021	$3.53B	-10.1%
Dec 2020	$3.92B	+14.8%
Sep 2020	$3.42B	+1.5%
Jun 2020	$3.37B	-3.4%
Mar 2020	$3.49B	-10.7%
Dec 2019	$3.91B	+10.0%
Sep 2019	$3.55B	-1.0%
Jun 2019	$3.59B	+7.7%
Mar 2019	$3.33B	-9.4%
Dec 2018	$3.68B	+12.8%
Sep 2018	$3.26B	-6.7%
Jun 2018	$3.50B	+6.4%
Mar 2018	$3.28B	-18.7%
Dec 2017	$4.04B	+9.9%
Sep 2017	$3.68B	-3.4%
Jun 2017	$3.81B	+9.6%
Mar 2017	$3.47B	-9.5%
Dec 2016	$3.84B	+12.9%
Sep 2016	$3.40B	-6.8%
Jun 2016	$3.65B	+10.4%
Mar 2016	$3.31B	-14.9%
Dec 2015	$3.89B	+12.2%
Sep 2015	$3.46B	-4.3%
Jun 2015	$3.62B	+10.2%
Mar 2015	$3.28B	-17.2%
Dec 2014	$3.97B	+11.2%
Sep 2014	$3.57B	-8.6%
Jun 2014	$3.90B	-10.0%
Mar 2014	$4.33B	+4.5%
Dec 2013	$4.15B	+12.8%
Sep 2013	$3.67B	-2.9%

Month	Value	Change
Jun 2013	$3.78B	-10.7%
Mar 2013	$4.24B	-8.6%
Dec 2012	$4.64B	+17.9%
Sep 2012	$3.93B	-5.2%
Jun 2012	$4.15B	+3.9%
Mar 2012	$3.99B	-13.5%
Dec 2011	$4.62B	-2.6%
Sep 2011	$4.74B	-5.2%
Jun 2011	$5.00B	+11.8%
Mar 2011	$4.48B	-11.9%
Dec 2010	$5.08B	+33.6%
Sep 2010	$3.80B	+7.9%
Jun 2010	$3.52B	-1.7%
Mar 2010	$3.58B	-18.8%
Dec 2009	$4.41B	+30.6%
Sep 2009	$3.38B	-4.4%
Jun 2009	$3.53B	+9.6%
Mar 2009	$3.23B	-12.4%
Dec 2008	$3.68B	+6.1%
Sep 2008	$3.47B	-5.5%
Jun 2008	$3.68B	+13.5%
Mar 2008	$3.24B	-12.0%
Dec 2007	$3.68B	+15.7%
Sep 2007	$3.18B	-4.1%
Jun 2007	$3.32B	+4.9%
Mar 2007	$3.16B	-9.5%
Dec 2006	$3.50B	-10.0%
Sep 2006	$3.88B	+32.6%
Jun 2006	$2.93B	+8.5%
Mar 2006	$2.70B	>+9,900.0%
Dec 2005	$0.00	0.0%
Sep 2005	$0.00	0.0%
Jun 2005	$0.00	0.0%
Mar 2005	$0.00	0.0%
Dec 2004	$0.00	0.0%
Sep 2004	$0.00	0.0%
Jun 2004	$0.00	0.0%
Mar 2004	$0.00	0.0%
Dec 2003	$0.00	0.0%
Sep 2003	$0.00	0.0%
Jun 2003	$0.00	0.0%
Mar 2003	$0.00	0.0%
Dec 2002	$0.00	0.0%
Sep 2002	$0.00	0.0%
Jun 2002	$0.00	0.0%
Mar 2002	$0.00	0.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	0.0%
Jun 2001	$0.00	0.0%
Mar 2001	$0.00	0.0%
Dec 2000	$0.00	-100.0%
Jun 2000	$1.65B	-

FAQ

What is the current quarterly SG&A of NVS?: As of today, NVS quarterly SG&A is $3.24B
What is NVS quarterly SG&A most recent change?: NVS quarterly SG&A was up +2.88% on June 30, 2026
What is 1-year change in NVS quarterly SG&A?: NVS quarterly SG&A is down -7.26% year-over-year
How far is NVS quarterly SG&A from its all-time high?: NVS quarterly SG&A is currently -36.15% below its historical high of $5.08B set on December 31, 2010
How does NVS quarterly SG&A rank versus sector peers?: NVS quarterly SG&A is higher than 99.44% of companies in Healthcare sector
When is NVS next earnings release?: The next earnings release for NVS is on October 27, 2026

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

TTM SG&A

$165.13B$1.88B-1.12%

June 30, 2026

Summary

Current Value: As of today, NVS TTM SG&A is $165.13B, down -1.12% on June 30, 2026
Historical Performance: NVS TTM SG&A is up +1150.79% year-over-year, up +1264.61% over the past 3 years
All-Time High Comparison: NVS TTM SG&A is currently -47.68% below its historical high of $315.64B set on an earlier date
3-Year Low Comparison: NVS TTM SG&A is at its 3-year low
Sector Comparison: NVS TTM SG&A is higher than 99.29% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM SG&A	Jun 30, 26	$165.13B	+1133.3%	+1150.8%	+1264.6%	+1029.0%
Annual SG&A	Dec 31, 25	$0.00	–	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Jun 30, 26	$3.24B	+2.9%	-7.3%	+4.9%	-13.6%
Price	Aug 19, 26	$160.69	+6.8%	+28.6%	+59.1%	+72.4%
TTM Operating Profit	Jun 30, 26	$16.21B	-0.1%	-5.5%	+44.4%	+46.0%
TTM D&A	Jun 30, 26	$5.65B	+4.1%	-4.6%	-20.3%	+9.4%
TTM Revenue	Jun 30, 26	$54.79B	+0.3%	+2.6%	+26.4%	+8.7%

TTM SG&A Highs

NVS TTM SG&A Highs Comparison
Period	High	Date	Current
1Y	$174.22B	N/A	-5.2%
3Y	$239.85B	N/A	-31.1%
5Y	$264.41B	N/A	-37.5%
All	$315.64B	N/A	-47.7%

TTM SG&A Lows

NVS TTM SG&A Lows Comparison
Period	Low	Date	Current
1Y	$165.13B	N/A	at low
3Y	$165.13B	N/A	at low
5Y	$165.13B	N/A	at low
All	$23.86B	N/A	+592.1%

TTM SG&A History

Month	Value	Change
Jun 2026	$13.14B	-1.9%
Mar 2026	$13.39B	+0.7%
Dec 2025	$13.30B	-0.3%
Sep 2025	$13.33B	+1.0%
Jun 2025	$13.20B	+3.2%
Mar 2025	$12.80B	+1.8%
Dec 2024	$12.58B	+0.3%
Sep 2024	$12.54B	+0.6%
Jun 2024	$12.47B	0.0%
Mar 2024	$12.47B	-0.4%
Dec 2023	$12.52B	+2.1%
Sep 2023	$12.26B	+1.3%
Jun 2023	$12.10B	-3.9%
Mar 2023	$12.59B	-4.7%
Dec 2022	$13.21B	-5.7%
Sep 2022	$14.01B	-4.6%
Jun 2022	$14.70B	-1.2%
Mar 2022	$14.87B	-0.1%
Dec 2021	$14.89B	+0.4%
Sep 2021	$14.83B	+1.4%
Jun 2021	$14.63B	+2.7%
Mar 2021	$14.24B	+0.3%
Dec 2020	$14.20B	+0.1%
Sep 2020	$14.18B	-0.9%
Jun 2020	$14.31B	-1.5%
Mar 2020	$14.53B	+1.1%
Dec 2019	$14.37B	+1.6%
Sep 2019	$14.14B	+2.1%
Jun 2019	$13.85B	+0.7%
Mar 2019	$13.76B	+0.3%
Dec 2018	$13.72B	-2.6%
Sep 2018	$14.08B	-2.9%
Jun 2018	$14.50B	-2.1%
Mar 2018	$14.81B	-1.3%
Dec 2017	$15.00B	+1.4%
Sep 2017	$14.79B	+1.9%
Jun 2017	$14.52B	+1.1%
Mar 2017	$14.36B	+1.2%
Dec 2016	$14.19B	-0.3%
Sep 2016	$14.24B	-0.4%
Jun 2016	$14.30B	+0.2%
Mar 2016	$14.27B	+0.2%
Dec 2015	$14.25B	-0.6%
Sep 2015	$14.33B	-0.7%
Jun 2015	$14.43B	-1.9%
Mar 2015	$14.71B	-6.7%
Dec 2014	$15.76B	-1.1%
Sep 2014	$15.94B	-0.7%
Jun 2014	$16.05B	+0.7%
Mar 2014	$15.93B	+0.6%
Dec 2013	$15.84B	-3.0%
Sep 2013	$16.34B	-1.6%

Month	Value	Change
Jun 2013	$16.60B	-2.2%
Mar 2013	$16.96B	+1.5%
Dec 2012	$16.72B	+0.1%
Sep 2012	$16.70B	-4.6%
Jun 2012	$17.51B	-4.6%
Mar 2012	$18.36B	-2.6%
Dec 2011	$18.84B	-2.4%
Sep 2011	$19.30B	+5.1%
Jun 2011	$18.36B	+8.8%
Mar 2011	$16.88B	+5.6%
Dec 2010	$15.99B	+4.3%
Sep 2010	$15.32B	+2.8%
Jun 2010	$14.90B	-0.1%
Mar 2010	$14.91B	+2.5%
Dec 2009	$14.55B	+5.3%
Sep 2009	$13.82B	-0.7%
Jun 2009	$13.92B	-1.0%
Mar 2009	$14.06B	-0.1%
Dec 2008	$14.07B	+0.0%
Sep 2008	$14.06B	+2.1%
Jun 2008	$13.77B	+2.7%
Mar 2008	$13.42B	+0.6%
Dec 2007	$13.34B	+1.4%
Sep 2007	$13.16B	-5.1%
Jun 2007	$13.86B	+2.9%
Mar 2007	$13.47B	+3.6%
Dec 2006	$13.01B	+36.8%
Sep 2006	$9.51B	+69.0%
Jun 2006	$5.63B	+108.5%
Mar 2006	$2.70B	>+9,900.0%
Dec 2005	$0.00	0.0%
Sep 2005	$0.00	0.0%
Jun 2005	$0.00	0.0%
Mar 2005	$0.00	0.0%
Dec 2004	$0.00	0.0%
Sep 2004	$0.00	0.0%
Jun 2004	$0.00	0.0%
Mar 2004	$0.00	0.0%
Dec 2003	$0.00	0.0%
Sep 2003	$0.00	0.0%
Jun 2003	$0.00	0.0%
Mar 2003	$0.00	0.0%
Dec 2002	$0.00	0.0%
Sep 2002	$0.00	0.0%
Jun 2002	$0.00	0.0%
Mar 2002	$0.00	0.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	0.0%
Jun 2001	$0.00	-100.0%
Mar 2001	$1.65B	0.0%
Dec 2000	$1.65B	0.0%
Jun 2000	$1.65B	-

FAQ

What is the current TTM SG&A of NVS?: As of today, NVS TTM SG&A is $165.13B
What is NVS TTM SG&A most recent change?: NVS TTM SG&A was down -1.12% on June 30, 2026
What is 1-year change in NVS TTM SG&A?: NVS TTM SG&A is up +1150.79% year-over-year
How does NVS TTM SG&A rank versus sector peers?: NVS TTM SG&A is higher than 99.29% of companies in Healthcare sector
When is NVS next earnings release?: The next earnings release for NVS is on October 27, 2026

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Data Sources & References

NVS Official Website www.novartis.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs